Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Amgen Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 134
» View wsbtradio.com items only
    May 22, 2013 |Story| Reuters
  1. Immune system cancer drugs tipped to be a $35 bln market

    Reuters
    * Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...

    Tags: GlaxoSmithKline PLC, Citigroup Incorporated, Health Treatments, Food and Drug Administration, Chemotherapy

  2. May 22, 2013 |Story| Reuters
  3. Immune system cancer drugs tipped to be a $35 billion market

    Reuters
    LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...

    Tags: GlaxoSmithKline PLC, Citigroup Incorporated, Health Treatments, Food and Drug Administration, Chemotherapy

  4. May 22, 2013 |Story| Reuters
  5. Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales

    Reuters
    Por Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...

    Tags: GlaxoSmithKline PLC, Citigroup Incorporated, Roche Holding AG, Novartis AG, Bristol Myers Squibb Company

  6. May 17, 2013 |Story| Reuters
  7. U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney

    Reuters
    May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...

    Tags: Citigroup Incorporated, Beazer Homes USA Incorporated, Aerospace Manufacturing, United Rentals Incorporated, Marketing

  8. May 16, 2013 |Story| Reuters
  9. Warning didn't change for-profit dialysis drug use

    Reuters
    NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than non-profit centers in 2008, says a new study. The researchers write...

    Tags: Medical Specialization, Anemia, Renal Failure, Stroke, Food and Drug Administration

  10. May 12, 2013 |Story| Los Angeles Times
  11. Lieuwe Westra wins Amgen Tour's first stage under brutal heat

    ESCONDIDO, Calif. — Lieuwe Westra, red-faced and shaking, was the winner of Sunday's first stage at the Amgen Tour of California, on a day when temperatures on the route were recorded as high as 105 degrees.
    ESCONDIDO, Calif. — Lieuwe Westra, red-faced and shaking, was the winner of Sunday's first stage at the Amgen Tour of California, on a day when temperatures on the route were recorded as high as 105 degrees. James Stemper, of the 5-hour Energy/...

    Tags: Lieuwe Westra, Tour of California, Peter Sagan

  12. May 12, 2013 |Story| Los Angeles Times
  13. Bill would regulate 'biosimilar' drugs

    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: Chemical Industry, Pharmaceuticals, Jerry Hill, Genentech Inc., Food and Drug Administration

  14. May 6, 2013 |Story| Los Angeles Times
  15. Amgen at a glance

    The company: Amgen Inc. Headquarters: Thousand Oaks Ticker: AMGN Employees: 18,000 Leadership: Robert A. Bradway, chief executive since May 2012 2012 revenue: $17.3 billion 2012 net income: $4.3 billion Stock price: $106.48 at Friday's close...
  16. May 6, 2013 |Story| Los Angeles Times
  17. Amgen aims to restock its medicine cabinet

    Amgen Inc. is a biotechnology company that develops medicines used in the treatment of cancer, kidney disease, arthritis, bone disease and other serious illnesses.
    Amgen Inc. is a biotechnology company that develops medicines used in the treatment of cancer, kidney disease, arthritis, bone disease and other serious illnesses. The Thousand Oaks company's top-selling products include arthritis medication Enbrel,...

    Tags: Ovarian Cancer, Kidney Disease, Anemia, Health Treatments, Arthritis

  18. May 5, 2013 |Story| Los Angeles Times
  19. A wife's Alzheimer's, a husband's obsession

    Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette.
    Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette. He was head lifeguard at a public pool in Phoenix, where his father owned a liquor store. She worked...

    Tags: Bank of America Corp., Dermatologists, Entertainment, Radio, Health and Medical Professionals

  20. May 3, 2013 |Story| Reuters
  21. Big drugmakers think small with nanomedicine deals

    Reuters
    * Nanomedicine promises greater precision and monitoring * Pfizer, Amgen, AstraZeneca among firms placing bets * Early-stage research but scientists see momentum building By Ben Hirschler LONDON, May 3 (Reuters) - Is nanomedicine the next big thing? A...

    Tags: Nanotechnology, Kaposi's sarcoma, Technology, Chemical Industry, Tel Aviv (Israel)

  22. May 1, 2013 |Story| Reuters
  23. U.S. RESEARCH ROUNDUP: Berkshire, Fortinet, Aetna, NextEra Energy

    Reuters
    May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including Berkshire Hathaway, Aetna and Fortinet Inc on Wednesday. HIGHLIGHTS * Aetna Inc : Credit Suisse, Jefferies, Susquehanna, others...

    Tags: Marketing, Quaker Chemical Corporation, MicroStrategy Incorporated, General Growth Properties, Inc., LifePoint Hospitals Inc.

 1  2 3 4 5 6 7 8 9 10 11-12Next >
Original site for Amgen Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Amgen Inc. Photos
Thousand Oaks-based biotechnology company Amgen Inc. ha...
(May 14, 2013)
 6: Amgen Inc.
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate ‘biosimilar’ drugs
, Rathmann was the Thousand Oaks firm's first chief exe...
(April 25, 2012)
George B. Rathmann